Literature DB >> 33634256

Association between dehydroepiandrosterone levels and cardiovascular risk in public sector health workers in a Peruvian region.

Ricardo J Rojas1,2, Janett V Chávez-Sosa3, Rosmery Gutierrez-Ajalcriña4, Salomón Huancahuire-Vega1.   

Abstract

Alterations in dehydroepiandrosterone sulfate (DHEAS) levels have been shown to affect the cardiovascular system. This study examined the associations between DHEAS levels and cardiovascular risk in workers of a public hospital in Lima, Peru. The analytical cross-sectional study was conducted at the Hospital de Huaycán, Peru. The cardiovascular risk was assessed in health workers using the Framingham score and categorized into high and low cardiovascular risk groups, and then the DHEAS levels of both groups were compared. Two hundred ninety-six health workers were studied, 67.2% showed low cardiovascular risk, 22.3% intermediate and 10.5% high. DHEAS levels were lower in the high cardiovascular risk group (2156.9 vs 2814.6 ng/mL; P < 0.05) and showed negative association (prevalence rate ratio 0.14, 95% IC 0.04-0.53; P < 0.05) in multivariable analysis (P < 0.05). DHEAS, glycosylated hemoglobin, pulse pressure and mean arterial pressure show an independent association with high cardiovascular risk in a group of health workers. Additional variables should be considered for cardiovascular risk assessment.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular diseases; dehydroepiandrosterone sulfate; risk factors

Year:  2020        PMID: 33634256      PMCID: PMC7901826          DOI: 10.1097/XCE.0000000000000219

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  22 in total

1.  Use of statins is associated with lower serum total and non-sex hormone-binding globulin-bound testosterone levels in male participants of the Rotterdam Study.

Authors:  Catherine E de Keyser; Filipe Valerio de Lima; Frank H de Jong; Albert Hofman; Yolanda B de Rijke; André G Uitterlinden; Loes E Visser; Bruno H Stricker
Journal:  Eur J Endocrinol       Date:  2015-06-01       Impact factor: 6.664

2.  Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men.

Authors:  Åsa Tivesten; Liesbeth Vandenput; Daniel Carlzon; Maria Nilsson; Magnus K Karlsson; Östen Ljunggren; Elizabeth Barrett-Connor; Dan Mellström; Claes Ohlsson
Journal:  J Am Coll Cardiol       Date:  2014-10-21       Impact factor: 24.094

Review 3.  Hormones and cardiovascular disease in older men.

Authors:  Bu B Yeap; Leon Flicker
Journal:  J Am Med Dir Assoc       Date:  2014-02-12       Impact factor: 4.669

4.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

Review 5.  DHEAS as a new diagnostic tool.

Authors:  Wattana Leowattana
Journal:  Clin Chim Acta       Date:  2004-03       Impact factor: 3.786

Review 6.  Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Ting-Ting Wu; Yuan Chen; Yun Zhou; Dilare Adi; Ying-Ying Zheng; Fen Liu; Yi-Tong Ma; Xiang Xie
Journal:  J Am Heart Assoc       Date:  2017-05-05       Impact factor: 5.501

7.  Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality.

Authors:  M Abdullah Said; Ruben N Eppinga; Erik Lipsic; Niek Verweij; Pim van der Harst
Journal:  J Am Heart Assoc       Date:  2018-01-22       Impact factor: 5.501

8.  Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents.

Authors:  Xing Huang; Qing-Kun Shen; Hong-Jian Zhang; Jia-Li Li; Yu-Shun Tian; Zhe-Shan Quan
Journal:  Molecules       Date:  2018-09-03       Impact factor: 4.411

9.  Cardiovascular Risk Factors and Dehydroepiandrosterone Sulfate Among Latinos in the Boston Puerto Rican Health Study.

Authors:  Monik C Jiménez; Katherine L Tucker; Fátima Rodriguez; Bianca C Porneala; James B Meigs; Lenny López
Journal:  J Endocr Soc       Date:  2018-12-03

Review 10.  Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis.

Authors:  Iván Cavero-Redondo; Barbara Peleteiro; Celia Álvarez-Bueno; Fernando Rodriguez-Artalejo; Vicente Martínez-Vizcaíno
Journal:  BMJ Open       Date:  2017-07-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.